 Our study suggests that tapering from high doses of glucocorticoids to lower doses may increase the risk of flare in patients with rheumatoid arthritis. Conversely, tapering from low doses of glucocorticoids to higher doses does not appear to increase the risk of flare. This article was authored by Giovanni Adami, Angelo Foscio, Davidi Gatti and others.